Benefits of omalizumab as add‐on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE

Marc Humbert, K. Surrey, S. Hedgecock et al.|Allergy|2004

Cited by 1.1k